HomeCompareWENAW vs PLD

WENAW vs PLD: Dividend Comparison 2026

WENAW yields 5063.29% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 WENAW wins by $70304199583241.97M in total portfolio value
10 years
WENAW
WENAW
● Live price
5063.29%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$70304199583247.88M
Annual income
$67,674,944,133,659,165,000.00
Full WENAW calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — WENAW vs PLD

📍 WENAW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodWENAWPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, WENAW + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
WENAW pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WENAW
Annual income on $10K today (after 15% tax)
$430,379.75/yr
After 10yr DRIP, annual income (after tax)
$57,523,702,513,610,285,000.00/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, WENAW beats the other by $57,523,702,513,606,250,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WENAW + PLD for your $10,000?

WENAW: 50%PLD: 50%
100% PLD50/50100% WENAW
Portfolio after 10yr
$35152099791626.89M
Annual income
$33,837,472,066,831,960,000.00/yr
Blended yield
96.26%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

WENAW
No analyst data
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WENAW buys
0
PLD buys
0
No recent congressional trades found for WENAW or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricWENAWPLD
Forward yield5063.29%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$70304199583247.88M$5.91M
Annual income after 10y$67,674,944,133,659,165,000.00$4,750,725.19
Total dividends collected$70126381934526.08M$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: WENAW vs PLD ($10,000, DRIP)

YearWENAW PortfolioWENAW Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$517,029$506,329.11$11,241$540.96+$505.8KWENAW
2$25,019,286$24,466,064.78$13,019$991.13+$25.01MWENAW
3$1,133,242,195$1,106,471,558.74$15,801$1,870.97+$1133.23MWENAW
4$48,051,212,061$46,838,642,912.48$20,609$3,701.21+$48051.19MWENAW
5$1,907,518,068,513$1,856,103,271,607.74$29,919$7,867.97+$1907518.04MWENAW
6$70,903,526,356,852$68,862,482,023,543.80$50,631$18,617.74+$70903526.31MWENAW
7$2,468,069,984,799,694$2,392,203,211,597,861.50$105,528$51,352.20+$2468069984.69MWENAW
8$80,463,110,629,918,740$77,822,275,746,183,060.00$287,364$174,449.42+$80463110629.63MWENAW
9$2,457,248,083,727,765,000$2,371,152,555,353,752,000.00$1,081,760$774,280.77+$2457248083726.68MWENAW
10$70,304,199,583,247,880,000$67,674,944,133,659,165,000.00$5,908,209$4,750,725.19+$70304199583241.97MWENAW

WENAW vs PLD: Complete Analysis 2026

WENAWStock

Anew Medical, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases. Anew Medical, Inc. is based in Omaha, Nebraska.

Full WENAW Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this WENAW vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WENAW vs SCHDWENAW vs JEPIWENAW vs OWENAW vs KOWENAW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.